LoginSignup
JAG

Jaguar Health

Stock
Stock
Ticker: JAGX
JAGX

Price

Price

CHART BY

Frequently asked questions

What is Jaguar Health's market capitalization?

The market capitalization of Jaguar Health is $11.22M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Jaguar Health?

Jaguar Health's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$708.72. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Jaguar Health's stock?

Currently, 1 analysts cover Jaguar Health's stock, with a consensus target price of $262.50. Analyst ratings provide insights into the stock's expected performance.

What is Jaguar Health's revenue over the trailing twelve months?

Over the trailing twelve months, Jaguar Health reported a revenue of $29.57M.

What is the EBITDA for Jaguar Health?

Jaguar Health's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$23.33M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Jaguar Health?

Jaguar Health has a free cash flow of -$7.58M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Jaguar Health have, and what sector and industry does it belong to?

Jaguar Health employs approximately 47 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.

What is the free float of Jaguar Health's shares?

The free float of Jaguar Health is 4.28M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$11.22M
EPS (TTM) 
-$708.72
Free Float 
4.28M
Revenue (TTM) 
$29.57M
EBITDA (TTM) 
-$23.33M
Free Cashflow (TTM) 
-$7.58M

Pricing

52W span
$2.14$92.40

Analyst Ratings

The price target is $262.50 and the stock is covered by 1 analysts.

Buy

1

Hold

0

Sell

0

Information

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the following segments: Animal Health and Human Health. The Animal Health segment is focused on development and commercialization of prescription and non-prescription products for companion and production animals. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Employees
47
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

Primary Ticker
JAGX
Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin